ABIGAIL LAFLEUR: Open Payments
NPI 1801167671 · BAY SAINT LOUIS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 10 payments from 7 companies in 2025. Trend: 2023 $104 · 2024 $308 · 2025 $165
Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $31 |
| Viatris Specialty LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: GEMTESA, YUPELRI, ZEPBOUND, FARXIGA, Cologuard Collection Kit, UBRELVY, BREZTRI, VRAYLAR.
Industry payments across MS — which companies pay providers there.
